Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Dual acting compounds for the treatment of psychiatric disorders

Dec. 1, 2004

Merck claims a series of CGRP receptor antagonists

Dec. 1, 2004

GABA-A receptor modulators described by NeuroSearch

Dec. 1, 2004

New compounds for the treatment of psychiatric and mood disorders

Dec. 1, 2004

Cognitive benefits found with donepezil in MS patients with verbal memory impairment

Dec. 1, 2004

Bleeding associated with serotonin reuptake inhibition

Dec. 1, 2004

Antiinflammatory agents in early development at Minophagen for pain, arthritis, etc.

Nov. 30, 2004

Combunox approved for short-term management of acute moderate/severe pain

Nov. 30, 2004

A new series of hydrazone derivatives patented by Daiichi

Nov. 29, 2004

Ivax claims oral formulations of cladribine

Nov. 29, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...